Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO
EMSCO开展的EUROPE试验结果:基于生物标志物的罗米司亭低危骨髓增生异常综合征疗效预测模型的前瞻性验证
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-022-01669-z
Kubasch, Anne Sophie; Giagounidis, Aristoteles; Metzgeroth, Georgia; Jonasova, Anna; Herbst, Regina; Diaz, Jose Miguel Torregrosa; De Renzis, Benoit; Götze, Katharina S; Huetter-Kroenke, Marie-Luise; Gourin, Marie-Pierre; Slama, Borhane; Dimicoli-Salazar, Sophie; Cony-Makhoul, Pascale; Laribi, Kamel; Park, Sophie; Jersemann, Katja; Schipp, Dorothea; Metzeler, Klaus H; Tiebel, Oliver; Sockel, Katja; Gloaguen, Silke; Mies, Anna; Chermat, Fatiha; Thiede, Christian; Sapena, Rosa; Schlenk, Richard F; Fenaux, Pierre; Platzbecker, Uwe; Adès, Lionel